These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19840361)

  • 1. Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study.
    Kim YK; Nieuwlaat R; Connolly SJ; Schulman S; Meijer K; Raju N; Kaatz S; Eikelboom JW
    J Thromb Haemost; 2010 Jan; 8(1):101-6. PubMed ID: 19840361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
    Vijenthira A; Le Gal G; Castellucci LA; Carrier M
    Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of vitamin K antagonist drug dose finding by replacement of the international normalized ratio by a bidirectional factor: validation of a new algorithm.
    Beinema MJ; van der Meer FJ; Brouwers JR; Rosendaal FR
    J Thromb Haemost; 2016 Mar; 14(3):479-84. PubMed ID: 26712475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
    Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
    J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
    Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
    Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation. A systematic review and meta-analysis.
    Belley-Cote EP; Hanif H; D'Aragon F; Eikelboom JW; Anderson JL; Borgman M; Jonas DE; Kimmel SE; Manolopoulos VG; Baranova E; Maitland-van der Zee AH; Pirmohamed M; Whitlock RP
    Thromb Haemost; 2015 Oct; 114(4):768-77. PubMed ID: 26158747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
    Singer DE; Hellkamp AS; Yuan Z; Lokhnygina Y; Patel MR; Piccini JP; Hankey GJ; Breithardt G; Halperin JL; Becker RC; Hacke W; Nessel CC; Mahaffey KW; Fox KA; Califf RM;
    J Am Heart Assoc; 2015 Mar; 4(3):e001349. PubMed ID: 25736441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
    Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
    J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy.
    Nieuwlaat R; Hubers LM; Spyropoulos AC; Eikelboom JW; Connolly BJ; Van Spall HG; Schulze KM; Cuddy SM; Stehouwer AC; Schulman S; Connolly SJ
    Thromb Haemost; 2012 Dec; 108(6):1228-35. PubMed ID: 23015161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant management of atrial fibrillation: the influence of dosing algorithm and recall schedule on time in therapeutic range.
    Swarna Nantha Y
    Fam Pract; 2015 Oct; 32(5):514-9. PubMed ID: 26251026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended International Normalized Ratio testing intervals for warfarin-treated patients.
    Barnes GD; Kong X; Cole D; Haymart B; Kline-Rogers E; Almany S; Dahu M; Ekola M; Kaatz S; Kozlowski J; Froehlich JB
    J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medication timing on anticoagulation stability in users of warfarin (the INRange RCT): study protocol for a randomized controlled trial.
    Heran BS; Allan GM; Green L; Korownyk C; Kolber M; Olivier N; Flesher M; Garrison S
    Trials; 2016 Aug; 17(1):391. PubMed ID: 27488365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.
    Carcas AJ; Borobia AM; Velasco M; Abad-Santos F; Díaz MQ; Fernández-Capitán C; Ruiz-Giménez N; Madridano O; Sillero PL;
    Trials; 2012 Dec; 13():239. PubMed ID: 23237631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project.
    Bernstein MR; John L; Sciortino S; Arambages E; Auletta D; Spyropoulos AC
    J Thromb Thrombolysis; 2020 Feb; 49(2):316-320. PubMed ID: 31898275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial.
    Boonyawat K; Wang L; Lazo-Langner A; Kovacs MJ; Yeo E; Schnurr T; Schulman S; Crowther MA
    Thromb Haemost; 2016 Aug; 116(3):480-5. PubMed ID: 27346552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
    Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
    J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of body mass index on 90-day warfarin requirements: a retrospective chart review.
    Soyombo BM; Taylor A; Gillard C; Wilson C; Bailey Wheeler J
    Ther Adv Cardiovasc Dis; 2021; 15():17539447211012803. PubMed ID: 34120532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.